7Baggers
 Celldex Therapeutics stock rating reiterated at Buy by H.C. Wainwright  Investing.com Thu, 02 Oct 2025 12:00:01 GMT
 H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)  StreetInsider Thu, 02 Oct 2025 10:45:38 GMT
 IBD Rating Upgrades: Celldex Therapeutics Flashes Improved Technical Strength  Investor's Business Daily Mon, 29 Sep 2025 07:00:00 GMT
 One Celldex Therapeutics Insider Raised Stake By 40% In Previous Year  富途牛牛 Thu, 25 Sep 2025 13:18:18 GMT
 Celldex announces new barzolvolimab data at EADV congress  TipRanks Wed, 17 Sep 2025 10:01:00 GMT
 published on: 2025-09-17 11:44:49  khodrobank.com Wed, 17 Sep 2025 02:18:56 GMT
 celldex therapeutics: a deep dive (nasdaq:cldx)  Seeking Alpha Tue, 16 Sep 2025 14:57:09 GMT
 Rockford Register Star: Local News, Politics & Sports in Rockford, IL  FinancialContent Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 14:01:34  Newser Fri, 05 Sep 2025 19:01:34 GMT
 target diversity creates opportunity in chronic urticaria  BioCentury Thu, 04 Sep 2025 00:56:00 GMT
 published on: 2025-09-03 03:10:59  خودرو بانک Tue, 02 Sep 2025 23:42:26 GMT
 published on: 2025-08-31 20:05:07  Newser Mon, 01 Sep 2025 01:05:07 GMT
 celldex halts barzolvolimab development for eoe  MSN Sun, 31 Aug 2025 22:53:30 GMT

Celldex Therapeutics, Inc
(NASDAQ:CLDX) 

CLDX stock logo

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The...

Founded: 1983
Full Time Employees: 127
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends